Assessment of neuropsychological testing
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Response from the Panel: We thank the neuropsychologists who wrote in response to "Assessment: Neuropsychological testing of adults. Considerations for neurologists." The correspondence indicates that this is an important area of dialogue between neurologists and neuropsychologists, and we are pleased that the Assessment stimulated this exchange of ideas as well as provided guidance to neurologists regarding neuropsychological evaluations. It was not our intention to undermine relationships between neurologists and neuropsychologists as suggested in several of the letters; we regard the collaboration of these two specialties as so integral that it can easily withstand critical examination. The dialogue is also timely because consulting relationships are being affected by an increasing emphasis on evidence-based medicine, the importance of outcome assessments as a means of guiding health services delivery, decreasing use of specialty services, and the need for cost containment. In this response, we reiterate the purpose and development of the Assessment and respond to the letters received.
The purpose of the Assessment is to aid neurologists who consult neuropsychologists in the course of caring for patients with known or suspected brain disorders. The Assessment described both the role and the limitations of neuropsychological testing in neurologic practice based on the available evidence. We did not address the many valuable contributions that neuropsychology has made to understanding the effects of brain disease on behavior. These contributions are impressive but are of limited importance in determining whether a neuropsychological consultation is needed and in aiding a neurologist in caring for the patient.
The neuropsychological assessment was initiated by the Therapeutics and Technology Assessment (TTA) Subcommittee of the American Academy of Neurology(AAN) because neuropsychological assessment is a common consultation made by neurologists and one for which re-examination might improve its utility for neurologists. The panel facilitator (Dr. Cummings) identified an expert panel to develop the …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Ann Yeh and Dr. Daniela Castillo Villagrán
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Special Article
Invited Article: Conflicts of interest for authors of American Academy of Neurology clinical practice guidelinesR. G. Holloway, C. J. Mooney, T.S.D. Getchius et al.Neurology, June 30, 2008 -
Article
Effects of Lewy body disease and Alzheimer disease on brain atrophy and cognitive dysfunctionSung Woo Kang, Seun Jeon, Han Soo Yoo et al.Neurology, April 03, 2019 -
Editorials
Immunotherapy and multiple sclerosisThe devil is in the detailsDennis Bourdette, Ruth Whitham et al.Neurology, May 03, 2010 -
Correspondence
Assessment of neuropsychological testingLawrence C. Hartlage et al.Neurology, October 01, 1997


